InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the complete record of transactions filed by FUCHS HENRY J, Director. Officer active across 2 companies, notably Mirati Therapeutics, Inc.. Aggregated, 5 reports have been logged. The latest transaction was filed on 15 March 2022 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations5 total
038,790 shares0
Common Stock
SEC:0001567619-22-007187:0·
012,840 shares0
Common Stock
SEC:0001567619-22-006718:0·
€107,9586,000 shares@ €17.993100.0% of flow
Common Stock
SEC:0001214659-22-002681:0·
02,546 shares0
Common Stock
SEC:0001214659-22-000847·
02,546 shares0
Common Stock
SEC:0001214659-22-000847:0·
5 of 5 declarations
About FUCHS HENRY J
Henry J. Fuchs is a Director and President of Worldwide R&D at Mirati Therapeutics, Inc. and BIOMARIN PHARMACEUTICAL INC. In his roles, he oversees research and development initiatives and contributes to the overall strategy of the companies. With a strong background in the pharmaceutical sector, he is committed to promoting innovation and improving patient outcomes.
